“Paid in Pounds” Sweepstakes Awards Producers with Premium Deworming Tools

Andy Swenson, David Evertson and Ross Pinkelman to receive Te Pari® prize package


DULUTH, Ga. (Sept. 12, 2019) — The “Paid in Pounds” sweepstakes, supported by LongRange® (eprinomectin), awarded three producers with a Te Pari prize package valued at more than $4,000 each. The following winners each received a heavy-duty loadbar set, V20 revolution injection gun and T10 scale indicator with Wi-Fi:


  • Andy Swenson, Swenson Cattle Company, Worden, Montana 
  • David Evertson, Evertson Ranches, Laramie, Wyoming
  • Ross Pinkelman, Bloomfield Veterinary Clinic, Bloomfield, Nebraska


The prize package will help winners quickly and accurately dose animals while saving time, cutting labor costs and creating a smoother cattle-working experience. “These tools make it easy to deworm responsibly,” said Doug Ensley, DVM, cattle technical marketing manager, Boehringer Ingelheim. “Producers can also improve efficiency by using a deworming product that is proven to last throughout the entire grazing period.”


LONGRANGE delivers up to 150 days of parasite control in a single, injectable dose.1 Dr. Ensley added, “Conventional dewormers only offer protection for the first 14 to 42 days of the grazing season. Season-long control from LONGRANGE helps cattle spend less time getting dewormed in the chute and more time gaining weight out in the pasture.”


Producers are encouraged to work with their veterinarian to develop an effective parasite control program for their operation. Boehringer Ingelheim is proud to offer the “Paid in Pounds” sweepstakes program to promote accurate dosing, and would like to extend a sincere thank you to everyone who entered. 


Each sweepstakes winner received a Te Pari prize package valued at more than $4,000.




Boehringer Ingelheim is the second largest animal health business in the world, with net sales of almost $4.7 billion (3.9 billion euros) worldwide in 2018, about 10,000 employees and a presence in more than 150 markets. We have pioneered advancements in vaccines, parasite-control products and therapeutics that limit pain and slow disease, and we aim to create the future of animal wellbeing for pets, horses and livestock by focusing on prevention.

 

Boehringer Ingelheim’s Animal Health Business has a significant presence in the United States, with more than 3,000 employees in places that include Georgia, Missouri, Iowa, Minnesota, New Jersey and Puerto Rico. To learn more, visit www.boehringer-ingelheim.us, www.facebook.com/BoehringerAHUS or www.twitter.com/Boehringer_AH.

 

About Boehringer Ingelheim

 

Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

 

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas: human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around $20.7 billion (17.5 billion euros). R&D expenditure of about $3.8 billion (3.2 billion euros), corresponded to 18.1 per cent of net sales.

 

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment. 


IMPORTANT SAFETY INFORMATION: Do not treat within 48 days of slaughter. Not for use in female dairy cattle 20 months of age or older, including dry dairy cows, or in veal calves. Post-injection-site damage (e.g., granulomas, necrosis) can occur. These reactions have disappeared without treatment. Please click here for full product information.


LONGRANGE®, THERAPHASE® and The Cattle Head Logo® are registered trademarks of Boehringer Ingelheim Animal Health USA Inc. All other trademarks are the property of their respective owners. ©2019 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-BOV-0118-2019



Reference:

1 Dependent upon parasite species, as referenced in FOI summary and LONGRANGE product label.